Syntro Pty Ltd (Syntro) provides Investigational Medicinal Product (IMP) management services, covering the manufacture, packaging, labelling, storage and distribution of IMPs. Established in 2020, Syntro has a manufacturing and warehousing facility located in Melbourne, Victoria, Australia. The company specialises in the provision of investigational product manufacturing and logistical services to local and international pharmaceutical companies plus research institutes conducting clinical trials. A key Syntro offering is the combination of manufacturing and logistics expertise within the Australasian region.
The Syntro team has unparalleled experience in the region for the GMP manufacture of small-scale batches of investigational products for use in early phase clinical trials, Syntro’s team has significant experience working with clinical researchers and biotech companies to support all IMP needs.
The company facility is built to Good Manufacturing Practices (GMP) standards and holds current Drugs, Poisons and Controlled Substances Licences (licence numbers: 22211853 and 24211854) from the Victorian Department of Health to Manufacture and Sell or Supply by Wholesale Poisons or Controlled Substances for Schedule 2, 3, 4, 8 and 9 Poisons. The company holds a TGA GMP licence (MI-2021-LI-10942-1) for the primary manufacture of non-sterile products and secondary packaging and labelling of sterile and non-sterile products.
The company has strong relationships within the pharmaceutical industry and research communities. Syntro’s executive team has significant knowledge and experience in drug development, allowing them to deliver a tailored solution for investigational product manufacturing.